Ellagica acid inhibits arylamine N-acetyltransferase activity and DNA adduct formation in human bladder tumor cell lines (T24 and TSGH 8301)

Urological Research

Volumn 29, Issue 6, 2001, Pages 371-376

  Lin, S ^a   Hung, C ^b   Tyan, Y ^c   Yang, C ^d   Hsia, T ^d   Yang, M ^d   Chung, J ^e  

^a CHUNGTAI INST HLTH SCI TECHNOL   (Taiwan)

^b JEN AI HOSPITAL   (Taiwan)

^c TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^d CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

2 aminofluorene; Bladder cancer; DNA adduct; N acetyl 2 aminofluorene; N acetyl P aminobenzoic acid; N acetyltransferase; P aminobenzoic acid

Indexed keywords

2 FLUORENYLAMINE; ARYLAMINE ACETYLTRANSFERASE; ELLAGIC ACID; 4 AMINOBENZOIC ACID; ANTINEOPLASTIC AGENT; DRUG DERIVATIVE; ENZYME INHIBITOR; FLAVONOID; N (2 FLUORENYL)ACETAMIDE; N-ACETYL-2-AMINOFLUORENE; PHENOL DERIVATIVE; POLYMER; POLYPHENOLS;

ADULT; AGED; ARTICLE; CASE REPORT; CONCENTRATION RESPONSE; CYTOSOL; DNA ADDUCT; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROTEIN DETERMINATION; TUMOR CELL LINE; BLADDER TUMOR; CELL CULTURE; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM;

2-ACETYLAMINOFLUORENE; 4-AMINOBENZOIC ACID; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ARYLAMINE N-ACETYLTRANSFERASE; DNA ADDUCTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELLAGIC ACID; ENZYME INHIBITORS; FLAVONOIDS; HUMANS; PHENOLS; POLYMERS; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS;

EID: 0035675067     PISSN: 03005623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002400100213     Document Type: Article

References (28)

1. The effects of dietary ellagic acid on rat hepatic and esophageal mucosal cytochromes P450 and phase II enzyme
2. Modulating effects of ellagic acid, vanillin and quercetin in rat medium term multi-organ carcinogenesis model
3. Dietary ellagic acid inhibits the enzymatic activity of CYP1A1 without altering hepatic concentrations of CYP1A1 or CYP1A1 mRNA
4. Human arylamine N-acetyltransferase genes: Isolation, chromosomal localization, and functional expression
5. Role of N-acetyltransferase phenotype in bladder carcinogenesis: A pharmacogenetic epidemiological approach to bladder cancer
6. Effects of the immunomodulator tilorone on the acetylation of 2-aminofluorene and DNA-2-aminofluorene adducts in rats
7. The statistical analysis of enzyme kinetic data
8. The effects of ellagic acid and 13-cis-retinoic acid on n-nitrosobenzylmethyl-induced esophageal tumorigenesis in rats
9. Mutagenicity of 30 chemicals in S. typhimurium possessing different nitroreductase or O-acetyltransferase activities
10. Age-associated risk of cancer among individuals with Nacetyltransferase 2 (NAT2) mutations and mutations in DNA mismatch repair genes
11. Monomorphic and polymorphic human arylamine N-acetyltransferase: A comparison of liver isoenzymes and expressed product of two cloned genes
12. N-acetylation phenotype and genotype and risk of bladder cancer in benzidine-exposed workers
13. N-acetyltransferase polymorphism: Comparison of phenotype and genotype in humans
14. Kinetics of acetyl CoA: Arylamine N-acetyltransferase from rapid and slow acetylator frog tissue
15. Ellagic acid inhibits arylamine N-acetyltransferase activity in rat bladder and colon tissue in vitro
16. Ellagic acid inhibited 2-aminofluorene and p-aminobenzoic acid acetylation by mononuclear leucocytes from Sprague-Dawley rats
17. Acetylator phenotype in colorectal carcinoma
18. Comparison of the polymorphic expression of N-acetyltransferase activity in human colon and bladder cytosol
19. Polymorphic expression of AcCoA-dependent arylamine N-acetyltransferase and AcCoA-dependent O-acetyltransferase activation of N-hydroxyarylamines by human bladder cytosol
20. Role of aromatic amines acetyltransferase in human colorectal cancer
21. Inhibition of N-nitrosobenzylmethylamine-induced esophageal tumorigenesis in rats by ellagic acid
22. Direct O-acetylation of N-hydroxylarylamines by acetylsalicyclic acid to from carcinogen-DNA adducts
23. Cloning and expression of cDNAs for polymorphic and monomorphic arylamine N-acetyltransferase N from human liver
24. Polyphenols as cancer chemopreventive agents
25. Inhibitory effect of ellagic acid on N-2-fluorenylacetamide-induced liver carcinogenesis in male AVI/N rats
26. N-acetylation pharmacogenetics
27. Inhibition by vitamin C of adduct formation and arylamine N-acetyltransterase activity in human bladder tumor cells